These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 4715777)
21. [Myasthenia and oral contraceptives (a case report)]. Kiehl U Z Arztl Fortbild (Jena); 1984; 78(4):153-4. PubMed ID: 6711038 [No Abstract] [Full Text] [Related]
22. Oral contraceptives and erythema nodosum: report of a case. Gelfand M Cent Afr J Med; 1982 Aug; 28(8):199-201. PubMed ID: 7172240 [No Abstract] [Full Text] [Related]
24. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol). Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970 [No Abstract] [Full Text] [Related]
25. Hypercarotenemia associated with an oral contraceptive. Malnick SD; Halperin M; Geltner D DICP; 1989 Oct; 23(10):811. PubMed ID: 2815859 [No Abstract] [Full Text] [Related]
26. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. Kearney BP; Mathias A Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945 [TBL] [Abstract][Full Text] [Related]
27. [Giant cell thromboangiitis in a patient taking an oral contraceptive (author's transl)]. Bakouche P; Vedrenne C; Beaumont V; Chaouat D; Reignier A; Nick J Rev Neurol (Paris); 1980; 136(8-9):509-19. PubMed ID: 7221328 [TBL] [Abstract][Full Text] [Related]
28. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol. Lippman JS; Shangold GA Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456 [No Abstract] [Full Text] [Related]
30. [The 2d generation of mini-pills]. Rozenbaum H Sem Hop Ther; 1976 Nov; 52(9):491-2. PubMed ID: 1006325 [No Abstract] [Full Text] [Related]
31. [Tri-Regol and its application in gynecological practice]. Marinov B; Kolarov G Akush Ginekol (Sofiia); 2000; 39(3):56-7. PubMed ID: 11188001 [TBL] [Abstract][Full Text] [Related]
32. [Hepatoblastoma in an infant after Estroprogestational intake by the mother during pregnancy]. Pilotti G; Bosco M; Leo D; Ricci C; Suria G Pediatr Med Chir; 1984; 6(2):323-5. PubMed ID: 6099553 [TBL] [Abstract][Full Text] [Related]
33. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents]. Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347 [No Abstract] [Full Text] [Related]
34. [Estrogen-gestagen and HDL-cholesterol]. Larsson-Cohn U; Wallentin L Lakartidningen; 1979 Mar; 76(10):836-7. PubMed ID: 218062 [No Abstract] [Full Text] [Related]
35. [Hormonal contraceptives in female rowers]. Lisý Z Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900 [No Abstract] [Full Text] [Related]
36. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives]. Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463 [No Abstract] [Full Text] [Related]
37. Hormonal supplementation as treatment for cyclical rashes in patients with systemic lupus erythematosus. Pando JA; Gourley MF; Wilder RL; Crofford LJ J Rheumatol; 1995 Nov; 22(11):2159-62. PubMed ID: 8596162 [TBL] [Abstract][Full Text] [Related]
38. [Lyndiol, a new low-dose oral contraceptive]. Altkemper R Med Monatsschr; 1973 Jul; 27(7):326-8. PubMed ID: 4727513 [No Abstract] [Full Text] [Related]
39. Erythema multiforme. Manganaro AM Gen Dent; 1996; 44(2):164-6. PubMed ID: 8690267 [TBL] [Abstract][Full Text] [Related]
40. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg. Christie T J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]